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Solution conformation 
and flexibility of capsular 
polysaccharides from Neisseria 
meningitidis and glycoconjugates 
with the tetanus toxoid protein
Ali Saber Abdelhameed1,2, Gordon A. Morris3, Fahad Almutairi4, Gary G. Adams1,5, 
Pierre Duvivier6, Karel Conrath6 & Stephen E. Harding1
The structural integrity of meningococcal native, micro-fluidized and activated capsular polysaccharides 
and their glycoconjugates – in the form most relevant to their potential use as vaccines (dilute solution) - 
have been investigated with respect to their homogeneity, conformation and flexibility. Sedimentation 
velocity analysis showed that the polysaccharide size distributions were generally bimodal with some 
evidence for higher molar mass forms at higher concentration. Weight average molar masses Mw where 
lower for activated polysaccharides. Conjugation with tetanus toxoid protein however greatly increased 
the molar mass and polydispersity of the final conjugates. Glycoconjugates had an approximately 
unimodal log-normal but broad and large molar mass profiles, confirmed by sedimentation 
equilibrium “SEDFIT MSTAR” analysis. Conformation analysis using HYDFIT (which globally combines 
sedimentation and viscosity data), “Conformation Zoning” and Wales-van Holde approaches showed 
a high degree of flexibility – at least as great as the unconjugated polysaccharides, and very different 
from the tetanus toxoid (TT) protein used for the conjugation. As with the recently published finding 
for Hib-TT complexes, it is the carbohydrate component that dictates the solution behaviour of these 
glycoconjugates, although the lower intrinsic viscosities suggest some degree of compaction of the 
carbohydrate chains around the protein.
Neisseria meningitidis, is a non-motile Gram negative oval bacterium, occurring typically in pairs, with adjacent 
sides flattened or concave1,2. Meningococcus is highly adapted to the human nasopharynx (suggesting a long and 
intimate commensal relationship with man) as well as being highly transformable bacterium, capable of acquiring 
and integrating DNA from a range of microbes with which it comes into contact3. It is principally known for its 
role in meningitis and other forms of meningococcal disease such as meningococcemia. N. meningitidis is a major 
cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in 
Africa and in Asia4. A small minority of those who become infected eventually will develop an acute inflamma-
tion of the meninges “meningitis”.
N. meningitidis is an encapsulated bacterium, with many isolates enveloped by a polysaccharide capsule, a 
major antigenic structure that used to classify meningococcal isolates by immunological means into serogroups. 
Each serogroup corresponds to a chemically and antigenically distinct capsular polysaccharide and, although 
13 distinct serogroups have been described5,6, virtually all isolates from invasive disease belong to one of six 
1National Centre for Macromolecular Hydrodynamics, University of Nottingham, Sutton Bonington LE12 5RD, 
UK. 2Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 
11451, Kingdom of Saudi Arabia. 3Department of Chemical Sciences, School of Applied Science, University of 
Huddersfield, Queensgate, Huddersfield, HD1 3DH, UK. 4Biochemistry Department, Faculty of Science, University 
of Tabuk, P.O. Box 741-Tabuk 71491 Saudi Arabia. 5Insulin and Diabetes Experimental Research (IDER) Group, 
University of Nottingham, Faculty of Medicine and Health Science, Clifton Boulevard, Nottingham NG7 2RD, UK. 
6GSK Vaccines, Rue de l’Institut 89, B1-330 Rixensart, Belgium. Correspondence and requests for materials should be 
addressed to A.S.A. (email: asaber@ksu.edu.sa) or S.E.H. (email: steve.harding@nottingham.ac.uk)
Received: 01 June 2016
Accepted: 21 September 2016
Published: 26 October 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:35588 | DOI: 10.1038/srep35588
serogroups, namely: A, B, C, W-135, X and Y7,8. Serogroup A meningococci are the major cause of the large, 
cyclic epidemics in Africa and Asia, while in industrialized nations 30–70% of the disease is caused by serogroup 
B organisms. Serogroup C meningococci are particularly associated with, usually, smaller-scale outbreaks world-
wide7–9. Serogroup X is more restricted to parts of sub-Saharan Africa9. Serogroup Y meningococci are currently 
accounting for over 30% of cases in the USA. Serogroup W-135 meningococci was associated with large outbreaks 
among pilgrims to the Hajj in Saudi Arabia in 2000 and was responsible for the epidemic in Burkina Faso in 
20026. The polysaccharide capsules of N. meningitidis are important determinants of virulence. Mutants without 
capsular expression are serum sensitive (i.e. killed by complement, and non-pathogenic). These polysaccharides 
are large, unbranched structures made up of O-acetylated residues in the 3 position of D-mannosamine-6 phos-
phate linked (1→ 6). These are O-acetylated repeating units of N-acetylmannosamine, linked with α -(1→ 6) phos-
phodiester bonds in case of serogroup A:
→ α → →‑ ‑ ‑ ‑p( 6) D Man NAc (3/4OAc) (1 OPO )3
(Ac = acetyl) or in case of serogroup C these are linear polymers made up of partly O-acetylated repeating 
units of sialic acid, linked with α -(2→ 9) glycosidic bonds:
→ α →‑ ‑ ‑ ‑( 9) D Neup5Ac(7/8OAc) (2 )
W-135 polysaccharide consists of partly O-acetylated alternating units of sialic acid and D-galactose, linked 
with α -(2→ 6) and α -(1→ 4) glycosidic bonds:
→ α− → α →‑ ‑ ‑ ‑ ‑ ‑p p( 6) D Gal (1 4) D Neu 5Ac(9OAc) (2 )
Neisseria meningitidis group Y polysaccharide consists of partly O-acetylated alternating units of sialic acid 
and D-glucose, linked with α -(2→ 6) and α -(1→ 4) glycosidic bonds:
→ α → α →‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑( 6) D Glcp (1 4) D Neup5Ac(9OAc) (2 )
see e.g.10–13. The first successful capsular polysaccharide vaccines against groups A and C were developed in 
response to epidemics of meningitis among US military recruits14,15. However, it was found that the meningo-
coccal polysaccharides proved to be poor immunogens in infants and fail to induce immunological memory in 
people of any age. Additionally, immune hypo-responsiveness is recorded after repeated vaccination with group C 
polysaccharide vaccine, which may cause difficulties for individuals who need long-term protection16. These dis-
advantages motivated extensive research to produce a polysaccharide-protein conjugate vaccine. Successes were 
subsequently achieved in the development of conjugate vaccines against Haemophilus influenzae type b (Hib) 
and Streptococcus pneumoniae thereby showing that the immunogenicity of polysaccharides could be improved 
by chemical conjugation to a protein carrier and eliciting a T-cell dependent anti-saccharide antibody response. 
The resulting polysaccharide – protein conjugate vaccines - are safe, immunogenic in young infants and induce 
long-term protection. In November 1999, meningococcal group C conjugate vaccine was introduced into routine 
immunisation in the UK17. Bivalent A plus C polysaccharide conjugate vaccines, have been assessed in clinical 
trials and were well tolerated and immunogenic in infants, toddlers, and adults18–20. Vaccine manufacturers have 
now developed conjugate vaccine combinations incorporating groups A, C, Y, and W-135 see e.g.11,21–23.
This present study investigates a recently FDA approved conjugate vaccine against serogroups A, C, W-135 
and Y namely, Nimenrix® produced by Pfizer Ltd., UK. The focus of this study has been sedimentation velocity 
in the analytical ultracentrifuge, together with sedimentation equilibrium and viscosity to examine the molecular 
integrity of the samples in terms of heterogeneity, molar mass distribution and conformational flexibility of puri-
fied native, micro-fluidized and activated (chemically modified to facilitate conjugation) capsular polysaccharides 
from N. meningitidis serogroups as well as meningococcal-tetanus toxoid (TT) conjugates. It follows our recent 
studies on (i) S. pneumoniae polysaccharides24; (ii) the tetanus toxoid protein25 and (iii) on the Hib-TT system26 
the latter study clearly demonstrating it was the carbohydrate polymer component rather than the protein which 
dictated the solution properties rather than the protein component for that glycoconjugate vaccine system. We 
now seek to establish if this is true also for the Men-TT system.
Results
Sedimentation coefficient distributions and molar mass. Analysis of the sedimentation coefficient 
distributions g*(s) vs s profiles in phosphate-chloride buffer (pH = 6.8, I = 0.10) showed that, in common with 
Hib polysaccharides26 the native Men polysaccharides are bimodal systems with the high molar mass components 
ranging from 5% by mass in native MenY to 20% in native MenA (for both Na+ and Ca2+ salts). The high molar 
mass component was relatively less significant at low concentrations. The micro-fluidized (M-F) Men polysac-
charides were characterized by lower sedimentation coefficients with the two components still present in M-F 
MenA. All other micro-fluidized Men polysaccharides appear to be mostly unimodal at different concentrations. 
The activated MenA and MenC polysaccharides were very nearly unimodal (Fig. 1). The bimodal structure of the 
polysaccharide distributions - particularly the native Men polysaccharides - are considered to be due to a higher 
degree of polymerization particularly for MenA Na+ and Ca2+ salts - see for example11. The g*(s) plots for all 
samples also showed the classical increase in the value of sedimentation coefficient s with the decrease in con-
centration, c, due to lowering non-ideality effects which vanish as c→ 0. After normalisation of s values measured 
in the buffer to standard solvent conditions (the viscosity and density of water at 20.0 °C) to give s20,w, standard 
reciprocal plots 1/s20,w vs c were used to obtain the non-ideality free s°20,w and concentration dependence Gralen 
values ks and are shown for comparison in Table 1.
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Sedimentation equilibrium was then used to determine average molar masses using the SEDFIT-MSTAR and 
MFIT algorithms which give weight-average molar masses and z-average molar masses, respectively for the prime 
parameters (Table 1, see also Fig. 2). With the glycoconjugates generally a very low rotor speed was required to 
register a measurable distribution at equilibrium. In the case of the Men A conjugates without spacer it was not 
possible to get a measurable distribution, so molar masses were obtained from comparison of the sedimentation 
coefficient values with Men A conjugates with spacer and MHKS power law coefficients b of 0.4 and 0.5, in the 
relation s ~ Mb, a range consistent with a macromolecule with a high degree of flexibility (see the consideration of 
conformation and flexibility below).
Figure 1. Sedimentation coefficient concentration distribution, least squares g*(s) vs s profile for ADH-
activated MenA in phosphate-chloride buffer pH~6.8, I = 0.1, at 20.0 °C at loading concentration between 
0.1–2.0 mg mL−1. Rotor speed = 45000 rpm. The plot has been normalized so that the main peak height is set to 
1 for each concentration. The steady movement of the distribution to higher s (decreasing non-ideality) as the 
concentration is decreased can be clearly seen.
Sample so20,w (S) ks (mL g−1) Mwa (kDa) Mzb (kDa)
Native polysaccharides
 MenA Na+ 6.4 ± 0.3 250 ± 50 710 ± 35 775 ± 40
 MenA Ca2+ 4.5 ± 0.2 100 ± 40 620 ± 30 700 ± 35
 MenC 6.2 ± 0.2 165 ± 35 1950 ± 100 1900 ± 95
 MenW135 9.8 ± 1.2 400 ± 120 1350 ± 70 1400 ± 70
 MenY 8.8 ± 0.7 470 ± 80 1370 ± 70 1630 ± 80
 M-F MenA 5.4 ± 0.2 195 ± 40 195 ± 10 240 ± 5
 M-F MenC 4.0 ± 0.2 190 ± 40 185 ± 10 170 ± 5
 M-F MenW135 2.7 ± 0.1 135 ± 20 275 ± 15 280 ± 20
 M-F MenY 2.4 ± 0.1 115 ± 10 110 ± 5 120 ± 5
Activated polysaccharides
 MenA-ADH 4.0 ± 0.1 170 ± 30 275 ± 15 350 ± 20
 MenC-ADH 4.3 ± 0.1 85 ± 25 220 ± 10 245 ± 5
Glycoconjugates
 MenA with spacer 40 ± 1 25 ± 10 7900 ± 390 8000 ± 400
 MenA-Na+ salt without spacer 44 ± 1 25 ± 5 10000c 9600d 10100c 9700d
 MenA-Ca2+ salt without spacer 33 ± 1 45 ± 15 4900c 5400d 4950c 5450d
 MenC with spacer 56 ± 2 55 ± 30 9500 ± 450 9800 ± 500
 MenC without spacer 31 ± 1 250 ± 65 7800 ± 350 7900 ± 360
 MenW135 without spacer 38 ± 1 80 ± 25 9800 ± 500 10300 ± 510
 MenY without spacer 44 ± 2 110 ± 90 10400 ± 450 10600 ± 480
Table 1.  Hydrodynamic properties of capsular polysaccharides and TT-glycoconjugates from N. 
meningitides. aSedimentation equilibrium SEDFIT-MSTAR analysis. bSedimentation equilibrium MFIT 
analysis. cFrom comparison of the so20,w values with that of MenA with spacer and assuming an MHKS  
b value = 0.4. dFrom comparison of the so20,w values with that of MenA with spacer and assuming an MHKS  
b value = 0.5. The standard errors quoted in this Table (and Tables 2 & 3) are due to the respective fits, taking 
into account other parameters such as error in the partial specific volume.
www.nature.com/scientificreports/
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Sedimentation coefficient distributions could then be transformed into distributions of molar masses for the 
Men-TT conjugates using the Extended Fujita Approach of Harding, et al.27 (Fig. 3)
The transformation is as follows:
= .f M s dM g s( ) (d / ) ( ) (1)
with
κ=M s( / ) (2)s
b1/
and
κ= . ⋅ −s M b sd /d (3)s
b b b1/ ( 1)/
b as referred to above is a conformation parameter that has already been estimated for number of polysaccharides 
in particular solvent conditions27 and κs can be found from equation (2) provided that at least one value of M (e.g. 
the weight average over the whole distribution, Mw from sedimentation equilibrium) is known for one value of 
s (e.g. the weight average s value).
Intrinsic viscosity. Intrinsic viscosity values resulting from three different extrapolation methods (due to 
Huggins, Kraemer and Solomon & Ciuta) are reported in Table 2. Consistent with the behaviour of the sedimen-
tation coefficients, the intrinsic viscosity results for the polysaccharides are decreasing with the size reduction and 
activation of native polysaccharide. Intriguingly they are generally lower for the glycoconjugates even though the 
sedimentation coefficients and molar masses are much higher, although still an order of magnitude higher than 
Figure 2. SEDFIT-MSTAR output for analysis of MenA with spacer conjugate in phosphate-chloride buffer 
pH~ 6.8, I = 0.1, at 20.0 °C and at a loading concentration of 0.3 mg mL−1. Rotor speed = 2000 rpm. (a) low 
resolution molar mass distribution; (b) log concentration versus the square of the radial displacement from 
the centre of rotation. (c) extrapolation of the M* function to the cell base to yield the “whole distribution” 
apparent weight average molar mass Mw,app = (7500 ± 540) kDa; (d) plot of the point average molar mass (local 
molar mass) – obtained by taking the derivative of the data from plot (b) versus local concentration c(r) in the 
analytical ultracentrifuge cell.
www.nature.com/scientificreports/
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for compact globular particles (including the tetanus toxoid protein25,26 and large molar mass spherical viruses28). 
Nonetheless they are lower than for the Hib-glycoconjugates26 indicating greater compaction.
Discussion
Based on the hydrodynamic data we can make some clear inferences about the conformation of the glycoconjugate
Wales-van Holde ratio. The Wales-van Holde ratio29, R = ks/[η] is perhaps the simplest guidance/indicator 
of a molecule conformational flexibility. The limits are ~1.6 for a compact sphere or a non-draining random coil, 
and ~0.1 for a stiff rod30. From Table 2, it can be seen that some of the purified native, micro-fluidized and acti-
vated capsular polysaccharides from N. meningitidis and the final conjugates have Wales-van Holde ratios corre-
sponding to flexible random coil structures. Native MenA-Na+, native MenY, M-F (microfluidized) MenC, M-F 
Men W135, M-F MenY, activated MenA, MenA-Ca2+ salt without spacer, MenC conjugate with spacer, MenC 
conjugate without spacer and MenY conjugate without spacer are showing more flexible structures according to 
their high R values.
Figure 3. f(M) distribution profile (molar mass axis on a logarithmic scale) from Extended Fujita analysis 
of the sedimentation velocity data for the MenC conjugate with spacer. Distributions for 2 plausible values 
for the sedimenation power law coefficient b are shown.
Sample
Huggins [η] 
(mL g−1)
Kraemer [η] 
(mL g−1)
Solomon-Ciuta 
[η] (mL g−1) ks/[η] f/f0
Native polysaccharides
 MenA Na+ 170 ± 10 170 ± 10 170 ± 5 1.4 6
 MenA Ca2+ 115 ± 15 117 ± 15 117 ± 15 0.8 8
 MenC 290 ± 5 284 ± 5 290 ± 5 0.6 13
 MenW135 530 ± 10 510 ± 5 520 ± 5 0.8 7
 MenY 415 ± 5 410 ± 5 410 ± 5 1.1 7
 M-F MenA 270 ± 10 280 ± 10 275 ± 10 0.7 3
 M-F MenC 120 ± 10 120 ± 5 120 ± 5 1.6 4
 M-F MenW135 100 ± 10 100 ± 10 100 ± 5 1.4 8
 M-F MenY 110 ± 5 105 ± 5 105 ± 5 1.1 6
Activated polysaccharides
 MenA-ADH 100 ± 5 105 ± 5 105 ± 5 1.6 6
 MenC-ADH 115 ± 5 115 ± 5 115 ± 5 0.7 4
Glycoconjugates
 MenA with spacer 30 ± 2 29 ± 2 30 ± 2 0.8 5
 MenA-Na+ salt without spacer 34 ± 3 34 ± 2 34 ± 2 0.8 -
 MenA-Ca2+ salt without spacer 29 ± 1 28 ± 1 29 ± 1 1.5 -
 MenC with spacer 46 ± 2 46 ± 2 46 ± 2 1.2 4
 MenC without spacer 170 ± 15 170 ± 15 170 ± 15 1.5 7
 MenW135 without spacer 125 ± 5 125 ± 5 125 ± 5 0.6 6
 MenY without spacer 89 ± 2 88 ± 2 88 ± 3 1.3 6
Table 2.  Intrinsic viscosity [η], Wales-van Holde ratio ks/[η]and frictional ratios f/f0.
www.nature.com/scientificreports/
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Translational frictional ratio. The translational frictional ratio, f/fo is a parameter which depends on con-
formation and molecular expansion through hydration effects31. It can be measured experimentally from the 
sedimentation coefficient and molar mass:
ρ
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where NA is Avogadro’s number, f is the friction coefficient of the molecule and fo the corresponding value for a 
spherical particle of the same mass and (anhydrous) volume31. Values of f/fo increase with increasing chain stiff-
ness, although they are also molar mass dependent. The values for the frictional ratio in Table 2 are also consistent 
with a flexible coil structure.
Persistence length Lp. For a more quantitative estimate of chain flexibility we can use the persistence 
length Lp, which has theoretical limits of 0 for a random coil and ∞ for a stiff rod. Practically the limits are 
∼ 1–2 nm for a random coil and ∼ 200–300 nm for a very stiff rod shaped macromolecule. Several methods are 
available for estimation of Lp using either intrinsic viscosity32,33 or sedimentation coefficient34,35 measurements. 
For example the relation32,33.
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where φ is the Flory-Fox coefficient (2.86 × 1023 mol−1) and A0 and B0 are tabulated coefficients, and the 
Yamakawa–Fujii equation34.
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Yamakawa and Fujii showed that A2 can be considered as –ln(d/2Lp) and A3 = 0.1382 if the Lp is much higher 
than the chain diameter, d. Difficulties arise if the mass per unit length is not known, although both relations have 
now been built into an algorithm Multi-HYDFIT35 which estimates the best estimates or best range of values of 
Lp and ML based on minimization of a target function Δ. An estimate for the chain diameter d is also required 
but extensive simulations have shown that the results returned for Lp are relatively insensitive to the value chosen 
for d which was fixed at an average of ∼ 0.8 nm see e.g.36,37 ML and Lp were treated as variables and the minimum 
value of the target function Δ was estimated on a 2D contour plot for each sample: an example is given in Fig. 4, 
and the values estimated for Men samples given in Table 3. All the values are consistent with flexible random coil 
structures, including the polysaccharides both prior and after conjugation.
These results are in support of suggesting highly flexible random coil structures. Molecular flexibility is 
increasing by size reduction and activation and more because of conjugation. The estimation for the mass per 
unit lengths within experimental errors are in good agreement with the predicted values from the repeating unit 
structures.
Sedimentation Conformation Zoning. Assignment of the conformation type or “zone”38,39 utilizes per-
sistence length Lp and mass per unit length ML parameters via plotting ksML versus [s]/ML, where [s] is given by:
Figure 4. ‘HYDFIT’ contour plots of mass per unit length ML versus persistence length Lp for M-F MenY. 
The contours of different colour correspond to different values of a target function: the minimum value 
(indicated by the cross) corresponds to the best fit. The plot yields Lp ~ 3.7 (nm) and ML ~ 3.1 × 109 (g mol−1 
cm−1) at the minimum target (error) function value of 0.05.
www.nature.com/scientificreports/
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A Conformation Zoning plot for native polysaccharides (Fig. 5) shows semi-flexible structures for native 
MenA in its Na+ salt which becomes more flexible in the Ca2+ salt. It also shows semi-flexible structures of native 
MenW135 and native MenY and more flexible random coil structure of native MenC. After the size reduction 
process “micro-fluidization” and the activation of the polysaccharides they are shown to be adopting semi-flexible 
structures. On the other hand, the zoning plot of meningococcal conjugates (Fig. 6) confirms the significant 
increase in the flexibility of the conjugates (Zone D – random coils) compared to their native, micro-fluidized 
and activated counterparts.
Sample ML (g mol−1 nm−1) Lp(nm)
Native polysaccharides
 MenA Na+ 570 ± 20 5.9 ± 0.5
 MenA Ca2+ 365 ± 15 6.2 ± 0.4
 MenC 325 ± 40 9.1 ± 0.7
 MenW135 670 ± 30 6.8 ± 0.5
 MenY 630 ± 20 7.1 ± 0.4
 M-F MenA 880 ± 20 13.5 ± 1.5
 M-F MenC 485 ± 20 4.1 ± 0.5
 M-F MenW135 220 ± 15 4.2 ± 0.4
 M-F MenY 310 ± 20 3.7 ± 0.3
Activated polysaccharides
 MenA-ADH 445 ± 15 4.5 ± 0.4
 MenC-ADH 450 ± 20 3.6 ± 0.2
Glycoconjugates
 MenA with spacer 1400 ± 70 3.6 ± 0.3
 MenA-Na+ salt without 
spacer 890 ± 60 6.5 ± 0.4
 MenA-Ca2+ salt without 
spacer 890 ± 50 8.8 ± 0.6
 MenC with spacer 1070 ± 50 1.8 ± 0.1
 MenC without spacer 900 ± 20 3.9 ± 0.2
 MenW135 without spacer 870 ± 20 3.0 ± 0.3
 MenY without spacer 900 ± 40 1.3 ± 0.4
Table 3.  Mass per unit length ML and chain flexibility (Lp) estimations from combining sedimentation and 
viscosity data through HYDFIT.
Figure 5. Conformation zoning plots of meningococcal native polysaccharides, showing either semi-
flexible (Zone C) or highly flexible random coil structures (Zone D). The other zones38,39 are A: rigid rod; B: 
rod; E: globular or branched
www.nature.com/scientificreports/
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Concluding Remarks
The conformation analyses suggest semi-flexible random coil structures for MenA Na+ salt, MenW135 and MenY 
polysaccharides and more flexible random coil structures for MenA Ca2+ salt and MenC polysaccharides. The 
micro-fluidization significantly reduced the viscosity and molar mass. Conformation of those micro-fluidized 
polysaccharides has changed to less flexible structures. Similarly the conformation of the activated polysaccha-
rides slightly changed to less semi-flexible structures, their molar masses have also decreased from the native pol-
ysaccharides. The conjugation process has altered the viscosity of the final conjugates and remarkably increased 
the molar masses of the final conjugates. However, the conformation of the conjugates has become more flexible 
than native, micro-fluidized and activated polysaccharides and that the conjugates are highly flexible chains or 
highly flexible random coil structures. The lower intrinsic viscosities compared with the native or activated pol-
ysaccharides is indicative of some degree of wrapping of the polysaccharide chains around the tetanus toxoid 
protein core, although, like with glyco-vaccines based on Hib26 it seems it is the carbohydrate polymer component 
which dictates the hydrodynamic properties of these substances.
Methods
Sample preparation. Preparation of polysaccharides was similar to that described for Streptococcus pneu-
moniae24. Prior to their conjugation, polysaccharides undergo size reduction by micro-fluidization in a high pres-
sure homogenizer, which significantly reduces the viscosity and is likely to enhance the polysaccharides reactivity 
during conjugation22,40,41. During the development of the quadrivalent conjugate vaccine used in this study, dif-
ferent conjugation chemistries have been used in coupling of the polysaccharides to the carrier protein using a 
spacer or direct linking them without a spacer. Hence, samples used in this study are native polysaccharides from 
serogroups C (MenC), W-135 (MenW135), Y (MenY) and serogroup A sodium salt (MenA-Na+) and calcium salt 
(MenA-Ca2+). Micro-fluidized polysaccharides from serogroups A, C, W-135 and Y, activated polysaccharides 
from serogroups A and C, were also examined. Serogroup A conjugate without spacer (MenA without spacer), 
sodium salt conjugate with spacer (MenA-Na+ with spacer), calcium salt conjugate with spacer (MenA-Ca2+ with 
spacer) and serogroup C conjugate with spacer (MenC with spacer), conjugate without spacer (MenC without 
spacer) and serogroup W-135 conjugate without spacer (MenW135 without spacer) and serogroup Y conjugate 
without spacer (MenY without spacer), were also investigated.
Polysaccharide-protein conjugation with a spacer. The covalent binding of the polysaccharides and 
the spacer adipic acid dihydrazide (ADH) is carried out using a coupling chemistry by which the polysaccharides 
are activated under controlled conditions by a suitable cyanylating agent, 1-cyano-4-dimethylamino-pyridinium 
tetrafluoroborate (CDAP) see e.g.41,42. CDAP reacts with the polysaccharide, exchanging a cyano group for 
hydroxyl hydrogen, hydroxyl groups being abundant on the polysaccharide, creating a highly reactive cyanoester. 
The activation is best done at pH 9–10, and in fact there is a strong pH dependence on CDAP polysaccharide 
(PS) activation efficiency40. The spacer reacts with the cyanylated-polysaccharide through its hydrazino groups, 
to form a stable isourea link between the spacer and the polysaccharide. The conjugation of the tetanus tox-
oid (TT) with PS-ADH consists of the covalent binding of the protein on the derivatized PS using 1-ethyl-3-(3
-dimethylaminopropyl) carbodiimide (EDC)43,44. A stable peptidic link is formed between the carboxylic group 
of the protein and the hydrazino group of the spacer (ADH).
Conjugation without a spacer. As an alternative to using a linker (spacer), direct linkage can be used. 
Activation of polysaccharides with CDAP introduces a cyano group in the polysaccharides and dimethylami-
nopyridine (DMAP) is liberated. The cyano group reacts with NH2-groups of the protein during the subsequent 
coupling phase leading to binding of the polysaccharide to the TT protein by a way of an isourea link.
Figure 6. As Fig. 5, but for meningococcal conjugates, showing highly flexible random coil structures 
(Zone D). 
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Prior to their purification, the conjugates are filtered through a 10 μ m membrane in order to remove poten-
tial aggregates. The conjugates are then purified on a Sephacryl S400HR column to remove the by-products and 
unbound protein and/or polysaccharides. They are finally sterile filtered on a 0.22 μ m membrane. All samples 
were dissolved in phosphate-chloride buffer pH~ 6.8, I = 0.145, at 20.0 °C. All solutions were then diluted to the 
appropriate concentrations required for the hydrodynamic characterisations.
Sedimentation velocity in the analytical ultracentrifuge. Sedimentation velocity experiments 
were performed using a Beckman (Palo Alto, CA, USA) Optima XL-I analytical ultracentrifuge equipped with 
Rayleigh interference optics and an automatic on-line data capture system. Conventional 12.0 mm double-sector 
epoxy cells with sapphire windows were loaded with 400 μ L of different concentrations (0.1–2.0 mg mL−1) of 
each sample and a matching amount of the corresponding reference buffer in appropriate channels. Native, 
micro-fluidized and activated capsular polysaccharides from N. meningitidis were centrifuged at 45000 rpm at 
a temperature of 20.0 °C, while the glycoconjugates solutions were spun at 7000 rpm and the same temperature. 
Concentration profiles in the analytical ultracentrifuge cell were recorded using the Rayleigh interference optical 
system and converted to concentration (in units of fringe displacement relative to the meniscus, j) versus radial 
position, r at particular times t46. Data were analysed using the least squares boundary modelling referred to as 
the least squares ls-g*(s) model incorporated into the SEDFIT algorithm47. SEDFIT generates an apparent distri-
bution of sedimentation coefficients in the form of g*(s) versus sT,b, where the (*) indicates that the distribution 
of sedimentation coefficients has not been corrected for diffusion effects, see e.g.46. The correction procedure 
requires assumptions about the friction coefficient not valid for continuous distributions of molecular weight/
sedimentation coefficient, although for large polysaccharides/glycoconjugates, these corrections will be small46. 
This was followed by the correction to standard solvent conditions-namely the density and viscosity of water at 
20.0 °C - to yield s20,W using the utility program SEDNTERP48. Note that to account for non-ideality (co-exclusion 
and backflow effects), the apparent sedimentation coefficient (s20,w) was calculated at a series of different cell load-
ing concentration and extrapolated to infinite dilution using the Gralén relation49:
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where ks is the Gralén or concentration dependence coefficient.
Sedimentation equilibrium (SE) in the analytical ultracentrifuge. Samples were prepared at 
a concentration of 0.3 mg/mL sufficiently low to minimize the effects of thermodynamic non-ideality. A vol-
ume of 1.0 ml of each sample was dialysed for 48 hours at the ambient temperature, each against 300 mL of the 
phosphate-chloride buffer. Sedimentation equilibrium experiments were also performed using the Beckman 
(Palo Alto, CA, USA) Optima XL-I analytical ultracentrifuge equipped with Rayleigh interference optics and an 
automatic on-line data capture system. The modified long (20.0 mm) optical path length double-sector titanium 
cells with sapphire windows were loaded with 0.15 mL of dialysed sample and a matching amount of reference 
buffer dialysate in appropriate channels. Samples were centrifuged at rotor speeds selected to give a sufficient 
fringe increment from meniscus to base50 i.e. 4000, 9000, 9000 and 2000 rpm for native, micro-fluidized, activated 
polysaccharides and glycoconjugates, respectively. Using the Rayleigh interference optical system, scans were 
taken every hour and equilibrium was reached after approximately 48 hours. Record of the relative concentration 
distribution of the solute at equilibrium was analysed to give the weight average apparent molar mass Mw,app using 
the SEDFIT-MSTAR algorithm51 based on an earlier algorithm of Cölfen and Harding52 and the M* function of 
Creeth and Harding53. The use of the long path length cells (20.0 mm) meant that low loading concentrations can 
be used to give a sufficient signal (~0.3 mg mL−1). At such low concentrations, non-ideality effects will be small 
and hence the apparent weight average molar mass will be approximately equal to the true weight average molar 
mass Mw. Mw from SEDFIT-MSTAR could then be combined with the weight average sedimentation coefficient 
to yield the molecular weight distribution54. We also estimate Mz using the MFIT algorithm of Ang and Rowe55.
Viscometry. Dynamic viscosity measurements for Men native, Men-ADH capsular polysaccharides and the 
Men-TT conjugate, were carried out using the automated micro-viscometer Anton Parr AMVn (Anton Parr, 
Graz, Austria) across a concentration series from 0.1–2.0 mg mL−1. The rolling ball viscosity method measures 
the time of a steel ball needed to roll in the 1.6 mm diameter silanized glass capillary containing each sample. 
The experiment was performed at different reclining angles of 70° (n = 4 times), 60° (n = 4 times) and 50° (n = 6 
times) under precise temperature control (20.00 ± 0.01) °C. Huggins56 and Kraemer57 extrapolations forms were 
performed to obtain the intrinsic viscosity, as described in ref 26. Intrinsic viscosities were also estimated using 
the Solomon – Ciutâ relation which represents a combination of the opposite trends of the Huggins and Kraemer 
relations allowing estimation of [η] without extrapolation58,59: Nonetheless as a check on consistency of data such 
estimates are still registered at different concentrations.
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